PPT-Integrating Routine HIV Screening Into Clinical Practice
Author : luna | Published Date : 2022-06-15
A Guide for Health Care Providers 2022 Overview HIV screening and testing in the United States Clinical benefits of early HIV diagnosis and treatment Advantages
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Integrating Routine HIV Screening Into ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Integrating Routine HIV Screening Into Clinical Practice: Transcript
A Guide for Health Care Providers 2022 Overview HIV screening and testing in the United States Clinical benefits of early HIV diagnosis and treatment Advantages of newer more sensitive HIV tests. Screening Initiation Cervical cancer screening should begin at age 21 or approximately 3 years after 64257rst intimate sexual activity whichever occurs later Intimate sexual activity includes intercourse as well as digital or oral sexual activity in Options The clinical practice options considered in formulating the guideline Outcomes Outcomes evaluated include antibiotic treatment efficacy and cure rates and the influence of the treatment of bacterial vaginosis on the rates of adverse pregnanc Radha Rajasingham, David Meya, Melissa Rolfes, Kate . Birkenkamp. , David R Boulware. Presented by: Radha Rajasingham, MD. July 23, 2012. Background. Cryptococcal Meningitis causes ~20-25% of AIDS-related attributable mortality in sub-Saharan Africa. nivolumab. Expanded Access . Programme. (EAP): preliminary data from a real-world population. Lucio . Crinò. et al.. Intervista a Angelo . Delmonte. Background:. Nivolumab is the first checkpoint inhibitor approved for the treatment of squamous non small cell lung cancer (Sq-NSCLC) to show a survival benefit in a randomised phase III trial. The experience of patients and physicians in routine clinical practice is often different from those in a controlled clinical trial setting. The purpose of this analysis is to evaluate nivolumab use in real world setting. . Thursday Feb. 2nd 2017 Noon – 1:00PM. Instructions to join the meeting remotely:. Open a web browser and enter URL: . www.readytalk.com. Enter participant access code: 2093166. Phone in for the audio portion of the conference:. The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention. Society of Maternal Fetal Medicine with the assistance . of Jennifer . McIntosh, MD; Helen . (A Gynecologist’s perspective). Palm Beach State College . Lunch and Learn Lecture Series. September 18, 2012. Dudley Brown, Jr., MD, MBA. Background:. BS in Psychology--University of Miami (Coral Gables). Roger Zoorob, MD, FAAFP Sandra J. Gonzalez, MSSW, LCSW Logistics of Effective Implementation Learning Objectives Understand the role of a clinical champion in the process of implementing alcohol SBI and FASD screening into their practice Patient Participation Group PPG Thursday 24 th January 2019 Welcome! Castle Place Practice Kennedy Way | Tiverton | Devon | EX16 6NP Castle Place Practice Agenda Welcome-All Introductions to the practice team present 1Programme Newborn Pulse Oximetry Screening BackgroundCongenital heart defects CHD are the most common group of congenital malformations and one of the leading causes of infant death in the developed Presentation By: . Elizabeth Darling, RM, PhD;. Alexa Minichiello, MSc. 1. . CPG Development. Process. Overview. 2. . Example . Recommendations. 3. . Knowledge . Translation Resources. CPG Development PROCESS. You are performing a routine lower limb peripheral neuropathy screening on a patient with weakness in the right lower limb and lower back pain. . All sensory and motor studies are normal except for the right tibial motor study to abductor hallucis (AH) which you notice is low in amplitude compared to the other side (>50%) and lower in amplitude compared to your normal values. What are your thoughts about the reason for this finding and what would your next actions be? . Host. – . Mandeep Singh . Ahluwalia. Speakers. – Mandeep Ahluwalia, Karen Burgess, Bikram Raychaudhuri, Jane Lodge and Amy Dissanayake. . . . The webinar will commence at 1pm. Please remember to turn off your mics and cameras. Thank you for joining the webinar. We will be starting shortly. Please ensure you place yourself on mute and turn off your camera. The webinar is about to start. Please mute yourself to reduce background noise (there will be time for Q&A at the end).
Download Document
Here is the link to download the presentation.
"Integrating Routine HIV Screening Into Clinical Practice"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents